Pharma Industry News
A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.
MTIP invests in pharma regulatory compliance provider Verifarma
A verification email is on its way to you. Please check your spam or junk folder just in case. If you do not receive this within five minutes, please try to sign in again. If the problem persists, please email:.
SG Americas Securities LLC Buys 234,629 Shares of Royalty Pharma PLC $RPRX
SG Americas Securities LLC lifted its stake in Royalty Pharma PLC (NASDAQ:RPRX - Free Report) by 438.0% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 288,202…
Zealand Pharma A/S (OTCMKTS:ZLDPF) Shares Up 9.1% - Here's Why
Shares of Zealand Pharma A/S (OTCMKTS:ZLDPF - Get Free Report) shot up 9.1% during mid-day trading on Monday. The stock traded as high as $44.71 and last traded at $44.71. 500 shares were traded during mid-day trading, a decline of 90% from the…
Astellas Pharma (OTCMKTS:ALPMY) Sets New 1-Year High - Time to Buy?
Astellas Pharma Inc. (OTCMKTS:ALPMY - Get Free Report)'s share price hit a new 52-week high on Monday. The company traded as high as $17.35 and last traded at $16.30, with a volume of 2014 shares changing hands. The stock had previously closed at…
Royalty Pharma PLC $RPRX Shares Sold by Cooper Investors PTY Ltd.
Cooper Investors PTY Ltd. lowered its stake in Royalty Pharma PLC (NASDAQ:RPRX - Free Report) by 5.4% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 386,440 shares of the…
Ascentage Pharma Group International - Unsponsored ADR (NASDAQ:AAPG) Receives Consensus Recommendation of 'Buy' from Analysts
Ascentage Pharma Group International - Unsponsored ADR (NASDAQ:AAPG - Get Free Report) has received a consensus rating of 'Buy' from the six analysts that are covering the company, Marketbeat.com reports. Five analysts have rated the stock with a…
These are Barclays' top defensive stocks. They also pay solid dividends
Investors looking to navigate the choppy market should consider certain defensive plays, according to Barclays. That's because it's become clear that geopolitics, oil, artificial intelligence disruption and private credit are no longer just side…
Eli Lilly, InSilico Strike AI Drug Discovery Deal
has signed a drug discovery deal with InSilico that the Hong Kong-listed biotech company says could be valued at as much as $2.75 billion. The partnership is the latest in a string of tie-ups between pharma majors and Chinese companies, and grants…
India Should Build Coalitions To Defend Consensus-Based Decision-Making at WTO: Interview
Chennai: The WTO's 14th Ministerial Conference (MC14) held in Cameroon ended without agreement on key issues, including e-commerce moratorium and expiry of safeguards against non-violation complaints against intellectual property policies. MC14 was…
CAG Flags Irregularities by TSIIC in Land Allotment
Hyderabad: The Comptroller and Auditor General of India (CAG) has flagged serious irregularities in land allotment and acquisition practices of the Telangana Industrial Infrastructure Corporation Limited (TSIIC) during the previous BRS regime…
Eli Lilly leans into AI drug discovery with new licensing deal
US pharmaceutical giant Eli Lilly inked a $2.75 billion deal with a Hong Kong-listed biotech firm to create new medicines using AI. Insilico Medicine, which develops drugs in China and went public in December, says it has produced at least 28…
India is the pharmacy of the world. But we are losing the drug development race
In India, it can take as much as two years just to get approval to start a clinical trial. By the time a firm starts a Phase I trial in India, the Chinese counterpart working on the same target would already have Phase II clinical data and have…
Graham Platner raised money with lobbyists days before taking nurses' fundraising pledge
Democratic U.S. Senate candidate Graham Platner fundraised with health care lobbyists in Washington days before he signed a pledge to reject campaign donations from the sector. The Sullivan oyster farmer is the frontrunner in the race to take on…
Nifty trades just 600 pts away from 52-week low, West Asia tensions, oil spike rattle markets, Sensex just 700 pts away
Selling pressure persisted on Dalal Street on Monday, with the benchmark indices trading sharply lower amid mounting geopolitical tensions and a spike in crude oil prices, pulling mid- and small-cap stocks further into negative territory. The…
Mark Cuban Calls Health Insurance 'The Most Hated Industry' And Says Politicians Don't Act to 'Break Them Up' - 'All Lip Service'
Billionaire Mark Cuban says big drug and insurance companies in the U.S. have grown too powerful to care about ordinary people, but policymakers aren't taking any real action to fix it. Speaking at the Punchbowl News Conference in Washington, DC…
Receive a Daily briefing on Pharma Industry News
Get Started